• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球哮喘防治创议指南 2024 年更新版

Global Initiative for Asthma Guidelines 2024: An Update.

机构信息

Division of Pediatric Pulmonology, Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

Division of Pediatric Pulmonology, Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India. Correspondence to: Dr Jagdish Goyal, Division of Pediatric Pulmonology, Department of Pediatrics, AIIMS, Jodhpur, Rajasthan, India.

出版信息

Indian Pediatr. 2024 Aug 15;61(8):781-786. Epub 2024 Jul 23.

PMID:39051318
Abstract

Asthma poses significant challenges in pediatric care, particularly in resource-limited settings. The Global Initiative for Asthma (GINA) 2024 guidelines represents a crucial step forward in addressing these challenges. This review critically evaluates the guidelines, focusing on their implementation and impact in developing countries like India. There have been certain key updates including a revised diagnostic flow chart and emphasis on alternative tools like peak flow meters. Challenges related to bronchodilator reversibility and interpreting FEV1/FVC are also explored. The article further addresses the implications of bronchial provocation testing in pediatric asthma. Detailed insights into cough-variant asthma highlight its rising recognition and management strategies. The GINA 2024 guidelines reflect updated criteria for commencing a particular step of therapy, aiming to optimize management and outcomes in pediatric asthma care. The guidelines have updated the role of allergen immunotherapy in pediatric asthma based on emerging evidence of efficacy and safety. Overall, the GINA 2024 guidelines offer a realistic approach to pediatric asthma care, with a potential for broader applications pending further research and adaptation.

摘要

哮喘在儿科护理中带来重大挑战,特别是在资源有限的环境中。2024 年全球哮喘倡议(GINA)指南代表着应对这些挑战的重要一步。本综述批判性地评估了这些指南,重点关注它们在印度等发展中国家的实施和影响。其中有一些关键更新,包括修订后的诊断流程图和强调替代工具,如峰流速仪。还探讨了与支气管扩张剂可逆性和解释 FEV1/FVC 相关的挑战。文章进一步探讨了支气管激发试验在儿科哮喘中的应用。详细介绍了咳嗽变异性哮喘,突出了其日益被认识和管理策略。2024 年 GINA 指南反映了开始特定治疗步骤的更新标准,旨在优化儿科哮喘管理和结果。该指南根据过敏原免疫疗法在儿科哮喘中的疗效和安全性的新证据更新了其在儿科哮喘中的作用。总的来说,2024 年 GINA 指南为儿科哮喘护理提供了一种现实的方法,在进一步研究和适应的基础上,具有更广泛应用的潜力。

相似文献

1
Global Initiative for Asthma Guidelines 2024: An Update.全球哮喘防治创议指南 2024 年更新版
Indian Pediatr. 2024 Aug 15;61(8):781-786. Epub 2024 Jul 23.
2
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
3
Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines.哮喘指南:与国家指南相关的全球哮喘防治创议
Curr Opin Allergy Clin Immunol. 2017 Apr;17(2):99-103. doi: 10.1097/ACI.0000000000000346.
4
A summary of the new GINA strategy: a roadmap to asthma control.新全球哮喘防治创议(GINA)策略总结:哮喘控制路线图
Eur Respir J. 2015 Sep;46(3):622-39. doi: 10.1183/13993003.00853-2015. Epub 2015 Jul 23.
5
A survey of asthma management practices and implementation of Global Initiative for Asthma guidelines among doctors in a resource-limited setting in Nigeria.尼日利亚资源有限环境下医生哮喘管理实践及全球哮喘防治创议指南实施情况的调查。
Niger J Clin Pract. 2017 Aug;20(8):984-991. doi: 10.4103/njcp.njcp_88_16.
6
It is time to change the way we manage mild asthma: an update in GINA 2019.是时候改变我们治疗轻度哮喘的方式了:GINA 2019 更新。
Respir Res. 2019 Aug 14;20(1):183. doi: 10.1186/s12931-019-1159-y.
7
The Global Initiative for Asthma (GINA): 25 years later.全球哮喘倡议(GINA):25 年后。
Eur Respir J. 2019 Aug 29;54(2). doi: 10.1183/13993003.00598-2019. Print 2019 Aug.
8
[Latin-American Consensus on Difficult-to-Control Asthma. 2008 Update].[拉丁美洲难治性哮喘共识。2008年更新]
Drugs Today (Barc). 2008 Jun;44 Suppl 3:1-43.
9
GINA guidelines on asthma and beyond.《全球哮喘防治创议》关于哮喘及其他相关疾病的指南。
Allergy. 2007 Feb;62(2):102-12. doi: 10.1111/j.1398-9995.2006.01305.x.
10
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care.《全球哮喘倡议(GINA)策略转化为改善护理的指南》
Eur Respir J. 2012 May;39(5):1220-9. doi: 10.1183/09031936.00184511. Epub 2012 Jan 26.

引用本文的文献

1
A Unified Pathogenesis of Allergic Diseases; The Protein-Homeostasis-System Hypothesis.过敏性疾病的统一发病机制;蛋白质稳态系统假说
Int J Mol Sci. 2025 Aug 28;26(17):8358. doi: 10.3390/ijms26178358.
2
The evolving landscape of digital inhaler platforms and adherence support in chronic airways disease.慢性气道疾病中数字吸入器平台与依从性支持的不断演变态势。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251366969. doi: 10.1177/14799731251366969. Epub 2025 Aug 8.
3
Evaluation of posterior segment changes in pediatric asthma patients with and without inhaled corticosteroid therapy.
对接受和未接受吸入性糖皮质激素治疗的小儿哮喘患者眼后段变化的评估。
Sci Rep. 2025 Aug 6;15(1):28793. doi: 10.1038/s41598-025-14024-w.
4
Carbon emissions from the increasing use of inhaled corticosteroid-LABA medications: a primary care used case from Singapore.吸入性皮质类固醇-长效β2受体激动剂药物使用增加导致的碳排放:来自新加坡的一个初级保健应用案例
NPJ Prim Care Respir Med. 2025 Aug 1;35(1):36. doi: 10.1038/s41533-025-00442-w.
5
Effectiveness and safety of acupuncture and related therapies for pediatric asthma: a systematic review and meta-analysis.针灸及相关疗法治疗小儿哮喘的有效性和安全性:一项系统评价与荟萃分析。
Front Med (Lausanne). 2025 Jul 16;12:1626830. doi: 10.3389/fmed.2025.1626830. eCollection 2025.
6
Serological markers, pulmonary function, and prognosis in pediatric asthma: predictive model development and validation.儿童哮喘的血清学标志物、肺功能与预后:预测模型的建立与验证
Am J Transl Res. 2025 Jun 15;17(6):4198-4212. doi: 10.62347/OPRX1666. eCollection 2025.
7
Association of Life's Essential 8 with all-cause mortality in asthma patients: evidence from NHANES 2005-2018.生命必需的八项指标与哮喘患者全因死亡率的关联:来自2005 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Nutr. 2025 Jun 17;12:1603875. doi: 10.3389/fnut.2025.1603875. eCollection 2025.
8
Differential Analysis of Hemogram Parameters and Cellular Ratios in Severe Asthma Exacerbations: A Comparative Study of Eosinophilic and Non-Eosinophilic Phenotypes.重度哮喘急性发作时血常规参数和细胞比例的差异分析:嗜酸性粒细胞型和非嗜酸性粒细胞型表型的比较研究
Life (Basel). 2025 Jun 18;15(6):970. doi: 10.3390/life15060970.
9
Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges.α-1抗胰蛋白酶缺乏症与支气管哮喘:当前挑战
Biomolecules. 2025 Jun 3;15(6):807. doi: 10.3390/biom15060807.
10
Sex-Based Differences in Asthma: Pathophysiology, Hormonal Influence, and Genetic Mechanisms.哮喘的性别差异:病理生理学、激素影响和遗传机制。
Int J Mol Sci. 2025 May 30;26(11):5288. doi: 10.3390/ijms26115288.